BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 24274763)

  • 1. The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells.
    Madkhali Y; Featherby S; Collier ME; Maraveyas A; Greenman J; Ettelaie C
    TH Open; 2019 Apr; 3(2):e132-e145. PubMed ID: 31259295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
    Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
    J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
    Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
    Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
    Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
    Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
    Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
    Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel downstream molecules of tissue factor activation by comparative proteomic analysis.
    Kask L; Jorsback A; Winkvist M; Alfredsson J; Ek B; Bergquist J; Siegbahn A
    J Proteome Res; 2014 Feb; 13(2):477-88. PubMed ID: 24274763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB; Rao LV
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging insights in tissue factor-dependent signaling events.
    Versteeg HH; Ruf W
    Semin Thromb Hemost; 2006 Feb; 32(1):24-32. PubMed ID: 16479459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray studies of factor VIIa-activated cancer cells.
    Petersen LC
    Thromb Res; 2008; 122 Suppl 1():S11-3. PubMed ID: 18691491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor--a receptor involved in the control of cellular properties, including angiogenesis.
    Chen J; Bierhaus A; Schiekofer S; Andrassy M; Chen B; Stern DM; Nawroth PP
    Thromb Haemost; 2001 Jul; 86(1):334-45. PubMed ID: 11487022
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.